Home
Research
A Phase 2a, Multicenter, Open-Label, Dose-EscalationStudy to Evaluate the Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for the Treatment of Dynamic Forehead Lines (Frontalis) Following Glabellar Line Injections

A Phase 2a, Multicenter, Open-Label, Dose-EscalationStudy to Evaluate the Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for the Treatment of Dynamic Forehead Lines (Frontalis) Following Glabellar Line Injections

Name: Vince Bertucci, MD, FRCPC: Bertucci MedSpa
Address: 8333 Weston Road, Suite 100, Woodbridge, ON, L4L 8E2
Telephone: (905) 850-4415

Inquire About This Study

Vince Bertucci, MD, FRCPC: Bertucci MedSpa
8333 Weston Road, Suite 100
Woodbridge, ON L4L 8E2
Phone: (905) 850-4415
Hours: Monday: 8 a.m.–5 p.m.
Tuesday: 9 a.m.–5 p.m.
Wednesday – Thursday: 8 a.m.–5 p.m.
Friday: 8 a.m.–4 p.m.

Trial Concludes: 04/22/2020

Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis)

This study evaluated the efficacy and safety of DAXI for injection in the treatment of dynamic Forehead Lines and to determine the responder rate of DAXI for injection in the treatment of Forehead Lines in conjunction with treatment for Glabellar Lines.

Inquire About This Study

Contact